287 related articles for article (PubMed ID: 34770947)
21. Efficient neutron capture therapy of glioblastoma with pteroyl-closo-dodecaborate-conjugated 4-(p-iodophenyl)butyric acid (PBC-IP).
Nishimura K; Kashiwagi H; Morita T; Fukuo Y; Okada S; Miura K; Matsumoto Y; Sugawara Y; Enomoto T; Suzuki M; Nakai K; Kawabata S; Nakamura H
J Control Release; 2023 Aug; 360():249-259. PubMed ID: 37356755
[TBL] [Abstract][Full Text] [Related]
22. Thermal Sensitive Liposomes Improve Delivery of Boronated Agents for Boron Neutron Capture Therapy.
Luderer MJ; Muz B; Alhallak K; Sun J; Wasden K; Guenthner N; de la Puente P; Federico C; Azab AK
Pharm Res; 2019 Aug; 36(10):144. PubMed ID: 31392417
[TBL] [Abstract][Full Text] [Related]
23. Cobalt bis(dicarbollide) versus closo-dodecaborate in boronated chlorin e(6) conjugates: implications for photodynamic and boron-neutron capture therapy.
Efremenko AV; Ignatova AA; Borsheva AA; Grin MA; Bregadze VI; Sivaev IB; Mironov AF; Feofanov AV
Photochem Photobiol Sci; 2012 Apr; 11(4):645-52. PubMed ID: 22262023
[TBL] [Abstract][Full Text] [Related]
24. Folate receptor-targeted novel boron compound for boron neutron capture therapy on F98 glioma-bearing rats.
Kanemitsu T; Kawabata S; Fukumura M; Futamura G; Hiramatsu R; Nonoguchi N; Nakagawa F; Takata T; Tanaka H; Suzuki M; Masunaga SI; Ono K; Miyatake SI; Nakamura H; Kuroiwa T
Radiat Environ Biophys; 2019 Mar; 58(1):59-67. PubMed ID: 30474719
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of boron cluster lipids: closo-dodecaborate as an alternative hydrophilic function of boronated liposomes for neutron capture therapy.
Lee JD; Ueno M; Miyajima Y; Nakamura H
Org Lett; 2007 Jan; 9(2):323-6. PubMed ID: 17217295
[TBL] [Abstract][Full Text] [Related]
26. Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy.
Luderer MJ; de la Puente P; Azab AK
Pharm Res; 2015 Sep; 32(9):2824-36. PubMed ID: 26033767
[TBL] [Abstract][Full Text] [Related]
27. Boron in cancer therapeutics: An overview.
Kulkarni S; Bhandary D; Singh Y; Monga V; Thareja S
Pharmacol Ther; 2023 Nov; 251():108548. PubMed ID: 37858628
[TBL] [Abstract][Full Text] [Related]
28. In vitro neutron irradiation of glioma and endothelial cultured cells.
Menichetti L; Gaetano L; Zampolli A; Del Turco S; Ferrari C; Bortolussi S; Stella S; Altieri S; Salvadori PA; Cionini L
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S336-40. PubMed ID: 19410472
[TBL] [Abstract][Full Text] [Related]
29. Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice.
Zavjalov E; Zaboronok A; Kanygin V; Kasatova A; Kichigin A; Mukhamadiyarov R; Razumov I; Sycheva T; Mathis BJ; Maezono SEB; Matsumura A; Taskaev S
Int J Radiat Biol; 2020 Jul; 96(7):868-878. PubMed ID: 32339057
[No Abstract] [Full Text] [Related]
30. Synthesis and cellular uptake of boron-rich pyrazolopyrimidines: exploitation of the translocator protein for the efficient delivery of boron into human glioma cells.
Crossley EL; Issa F; Scarf AM; Kassiou M; Rendina LM
Chem Commun (Camb); 2011 Nov; 47(44):12179-81. PubMed ID: 21993200
[TBL] [Abstract][Full Text] [Related]
31. [A uniform approach to the synthesis of carbohydrate conjugates of polyhedral boron compounds as potential agents for boron neutron capture therapy].
Orlova AV; Kondakov NN; Zinin AI; Kimel' BG; Kononov LO; Sivaev IB; Bregadze VI
Bioorg Khim; 2006; 32(6):632-42. PubMed ID: 17180914
[TBL] [Abstract][Full Text] [Related]
32. Strategies for the design and synthesis of boronated nucleic acid and protein components as potential delivery agents for neutron capture therapy.
Wyzlic IM; Tjarks W; Soloway AH; Anisuzzaman AK; Rong FG; Barth RF
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1203-13. PubMed ID: 8175406
[TBL] [Abstract][Full Text] [Related]
33. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
[TBL] [Abstract][Full Text] [Related]
34. Terminal Mono- and Bis-Conjugates of Oligonucleotides with
Novopashina DS; Vorobyeva MA; Lomzov AA; Silnikov VN; Venyaminova AG
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375375
[TBL] [Abstract][Full Text] [Related]
35. Carboranyl bisglycosides for the treatment of cancer by boron neutron capture therapy.
Tietze LF; Bothe U; Griesbach U; Nakaichi M; Hasegawa T; Nakamura H; Yamamoto Y
Chembiochem; 2001 May; 2(5):326-34. PubMed ID: 11828461
[TBL] [Abstract][Full Text] [Related]
36. Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
Chandra S; Ahmad T; Barth RF; Kabalka GW
J Microsc; 2014 Jun; 254(3):146-56. PubMed ID: 24684609
[TBL] [Abstract][Full Text] [Related]
37. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
[TBL] [Abstract][Full Text] [Related]
38. Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy.
Wu G; Barth RF; Yang W; Lee RJ; Tjarks W; Backer MV; Backer JM
Anticancer Agents Med Chem; 2006 Mar; 6(2):167-84. PubMed ID: 16529539
[TBL] [Abstract][Full Text] [Related]
39. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
[TBL] [Abstract][Full Text] [Related]
40. Boron Vehiculating Nanosystems for Neutron Capture Therapy in Cancer Treatment.
Ailuno G; Balboni A; Caviglioli G; Lai F; Barbieri F; Dellacasagrande I; Florio T; Baldassari S
Cells; 2022 Dec; 11(24):. PubMed ID: 36552793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
